BeOne Medicines (ONC) Other Working Capital Changes (2017 - 2024)

BeOne Medicines (ONC) has reported Other Working Capital Changes for 12 consecutive years, with $6.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 50.1% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at -$4.9 million (down 118.56% YoY), while the FY2025 annual figure was $1.3 million, down 88.42% from the prior year.
• Other Working Capital Changes rose to $6.2 million in Q1 2026 per ONC's latest filing, from -$8.3 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $75.1 million in Q2 2025 and bottomed at -$100.6 million in Q3 2025.
• Historically, Other Working Capital Changes has averaged -$6.3 million across 5 years, with a median of -$13.0 million in 2023.
• Annual changes were most pronounced in 2023 — Other Working Capital Changes jumped 740.04% — and 2025, when it sank 2251.84%.
• BeOne Medicines' Other Working Capital Changes stood at -$39.0 million in 2022, then jumped by 740.04% to $249.6 million in 2023, then plunged by 100.14% to -$353000.0 in 2024, then tumbled by 2251.84% to -$8.3 million in 2025, then surged by 174.34% to $6.2 million in 2026.
• Business Quant data shows ONC's Other Working Capital Changes at $6.2 million in Q1 2026, -$8.3 million in Q4 2025, and -$5.5 million in Q3 2025.